NCT05287464 2025-11-26International Multicentric Study ARON-1Hospital of MacerataRecruiting1,220 enrolled
NCT04682587 2025-01-03To Examine the Effects of Axitinib Dose Reduction and Interruption for Adverse Event Management Among Patients Receiving Axitinib in for the Treatment of Advanced Renal Cell CarcinomaPfizerCompleted481 enrolled 14 charts